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Abstract – Bone is a biomaterial undergoing continuous renewal. The renewal process is known as bone
remodelling and is operated by bone-resorbing cells (osteoclasts) and bone-forming cells (osteoblasts). An
important function of bone remodelling is the repair of microcracks accumulating in the bone matrix due
to mechanical loading. Cell-cell communication between cells of the osteoclastic lineage and cells of the
osteoblastic lineage is thought to couple resorption and formation so as to preserve bone integrity and achieve
homeostatic bone renewal. Both biochemical and biomechanical regulatory mechanisms have been identified in
this coupling. Many bone pathologies are associated with an alteration of bone cell interactions and a consequent
disruption of bone homeostasis. In osteoporosis, for example, this disruption leads to long-term bone loss and
fragility, and can ultimately result in fractures.
Here we focus on an additional and poorly understood potential regulatory mechanism of bone cells, that
involves the morphology of the microstructure of bone. Bone cells can only remove and replace bone at a
bone surface. However, the microscopic availability of bone surface depends in turn on the ever-changing
bone microstructure. The importance of this geometrical dependence is unknown and difficult to quantify
experimentally. Therefore, we develop a sophisticated mathematical model of bone cell interactions that
takes into account biochemical, biomechanical and geometrical regulations. We then investigate numerically
the influence of bone surface availability in bone remodelling within a representative bone tissue sample.
Biochemical regulations included in the model involve signalling molecules of the receptor–activator nuclear
factor κB pathway (RANK–RANKL–OPG), macrophage colony-stimulating factor (MCSF), transforming growth
factor β (TGFβ) and parathyroid hormone (PTH). For the biomechanical regulation of bone cells, a multiscale
homogenisation scheme is used to determine the microscopic strains generated at the level of the extravascular
matrix hosting the osteocytes by macroscopic loading. The interdependence between the bone cells’ activity,
which modifies the bone microstructure, and changes in the microscopic bone surface availability, which in turn
influences bone cell development and activity, is implemented using a remarkable experimental relationship
between bone specific surface and bone porosity. Our model suggests that geometrical regulation of the
activation of new remodelling events could have a significant effect on bone porosity and bone stiffness. On
the other hand, geometrical regulation of late stages of osteoblast and osteoclast differentiation seems less
significant. We conclude that the development of osteoporosis is probably accelerated by this geometrical
regulation in cortical bone, but probably slowed down in trabecular bone.
Key words: mechanical feedback, geometrical feedback, specific surface, bone remodelling, bone stiffness,
osteoporosis
1 Introduction
Bone is a biomaterial that has a variety of physiological
functions. In addition to load bearing and support for
locomotion, bone protects internal organs and participates
in calcium and phosphorous homeostasis. From an en-
gineering perspective the structural function of bone is
most importantly characterised by its stiffness and strength.
Daily activities (such as walking and running) subject bone
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to periodical loads which, over extended periods of time
(weeks, months and years), can lead to fatigue damage and
the formation of microcracks. If these microcracks are not
removed in due time, their evolution may result in a macro-
scopic structural failure, i.e., a fragility fracture. To prevent
the occurrence of fatigue fractures, nature has equipped
bone tissues with a cellular mechanism of self-repair [1],
referred to by biologists as ‘bone remodelling’ [2, 3]. Bone
remodelling is a coordinated process of bone resorption by
cells called osteoclasts, and bone formation by cells called
osteoblasts. Osteoclasts and osteoblasts usually operate
together in self-contained groups processing the renewal
of a localised portion of the bone tissue. These groups
are called bone multicellular units (BMUs) and constitute
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a single ‘remodelling event’. There are about 1.7 · 106 such
BMUs in a normal adult skeleton [2–4]. Cell population
and cell activity in a BMU are tightly controlled to establish
local bone homeostasis (i.e., balanced bone resorption and
bone formation). In bone pathologies, this cellular control
is perturbed and homeostatic bone renewal is disrupted.
In osteoporosis, bone is progressively lost, which results in
reduced bone stiffness and strength.
Over the last decades, bone biologists have identified
a large number of biochemical regulatory factors influ-
encing bone remodelling. The formation of osteoclasts
has been shown to rely crucially on macrophage colony-
stimulating factor (MCSF) and on the receptor-activator
nuclear factor κB (RANK) cell signalling pathway, which
involves the receptor RANK, the ligand RANKL and osteo-
protegerin (OPG) [5, 6]. RANKL activates the RANK receptor
on precursor osteoclasts, which triggers their development
and sustains their activity. The soluble molecule OPG is
a decoy receptor of RANKL which can prevent RANKL from
binding to RANK. Another important molecule mediating
the communication between osteoblasts and osteoclasts is
transforming growth factor β (TGFβ). TGFβ is stored in
high concentrations in the bone matrix. It is released into
the bone microenvironment, where it exerts its action on
several bone cells, during bone matrix resorption by active
osteoclasts [6]. The existence of a mechanical regulation of
bone remodelling has long been suspected. It is now well
established that mechanical feedback is a key regulatory
mechanism to maintain bone mass [7–12]. The commonly
accepted view is that osteocytes act as mechanosensors
that transduce local mechanical signals into biochemical
responses. These biochemical responses are thought to
regulate the initiation of bone remodelling processes and
to modulate the coupling between bone resorption and
formation (see e.g. [1] and Refs cited therein).
The existence of biochemical and biomechanical reg-
ulations of bone cells is well-established and has been
extensively studied. However, the notion that the mor-
phology of the microstructure of bone may induce an
additional regulation of bone cells of purely geometrical
nature is not often mentioned in the recent literature. This
may be due to the experimental difficulty of assessing the
importance of a geometrical regulation. Biochemical and
biomechanical regulations can experimentally be partially
or fully repressed by selective gene knock-outs or mono-
clonal antibodies targeting key components in the bone
cell signalling pathways. By contrast, one cannot simply
“switch off” a geometrical regulation of bone remodelling
when this self-repair process modifies the microstructure
(and so the geometry) of the material.
Bone tissue is diverse and exhibits a broad variety of
microstructures. However, two distinctive types of bone
tissue are usually identified: cortical bone and trabecular
bone [3] (see images in Figure 1). Cortical bone has typical
porosities of 0.05–0.15 while trabecular bone has typical
porosities of 0.65–0.85 [2, 3]. Mathematical models for
the estimation of mechanical properties of bone tissue have
shown that bone stiffness is predominantly determined by
the porosity fvas,
1 the interaction of the different mate-
1The total porosity of bone is made of a vascular porosity, which con-
rial phases and pore shape, while other microstructural
characteristics such as the exact pore distribution play a
secondary role [14–16]. For biochemical processes, pore
morphology can be expected to play a significant role.
Indeed, pore morphology determines the so-called specific
surface SV (i.e., the amount of bone surface available in
a representative volume element), which is an essential
geometrical factor for the bone cells. Bone cells require
a bone surface to fulfill their functions, whether to initiate
a bone remodelling process or to operate resorption and
formation. Osteoclasts require attachment to a particular
area of the bone surface before resorbing. Osteoblasts are
observed to only secrete osteoid (a collagen-rich substance
which later mineralises and becomes new bone matrix) on
existing bone surfaces. Finally, mechanical signals sensed
by osteocytes embedded in the bone matrix are passed
on to bone cells in the vascular cavity through the bone
surface. Effects similar to chemical exchange reactions
between pore walls and solutes in fluid-saturated porous
materials can be expected to occur in this context.
The issue of quantifiying the role of bone surface avail-
ability in bone remodelling was raised by bone biologists
already some time ago [2, 13, 17]. In Ref. [13], Martin
provides a first attempt to investigate theoretically the
effect of a geometrical regulation of bone remodelling in
osteoporosis (see Figure 1). Osteoporosis is associated
with increased porosity in both cortical and trabecular
bone [18]. In Martin’s own words: “In [cortical] bone,
increased porosity provides more surface area on which cells
can work, thereby increasing the capacity for further porosity
changes. In [trabecular] bone, increased porosity decreases
the amount of surface available to the cells, thereby decreas-
ing the capacity for further remodelling.”
While the proposed mechanism of geometrical feedback
on bone remodelling seems plausible, it is difficult to test
its validity experimentally and to determine its impor-
tance quantitatively. Some researchers have employed the
concept of geometrical feedback for simulations of bone
remodelling [21]. However, to our knowledge, there is no
systematic study in the literature of the effects of a possible
geometrical regulation at several stages of the remodelling
sequence. Also, the interplay between geometrical feed-
back and mechanical feedback in bone remodelling has not
been investigated. A mechanical feedback has the potential
to stabilise bone loss or gain [7, 22] and may either com-
pete with or enhance the effect of the geometrical feedback
seen in Figure 1 depending on the type of bone.
The aim of this paper is to address the above questions
using a state-of-the-art computational model of bone re-
modelling. The following questions related to geometrical
feedback are investigated: (i) At which stage of the bone
remodelling sequence (i.e., activation, resorption, forma-
tion) does geometrical feedback have the strongest effect?;
tains marrow components, blood vessels, bone cells and their precurors,
and the lacunae-canaliculi porosity, which contains osteocytes and their
processes. The lacunae-canaliculi porosity is only a small fraction of the
total porosity (see e.g. [13, Table 1]) and no remodelling occurs at these
surfaces. Therefore, the lacunae-canaliculi porosity will not be consider
in this work and we will refer to the vascular porosity simply as the bone
porosity. Similarly, in the present context, we are not interested in the
intercrystalline and intermolecular porosities, which we simply regard as
part of the ‘solid bone matrix’.
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Figure 1 – Schematic representation of a possible effect of geometrical
feedback on the evolution of vascular porosity ( fvas) in osteoporosis
both in cortical bone (lower curves) and trabecular bone (upper curves)
according to Martin [13]. Dashed curves show the linear increase
in porosity that is obtained without geometrical feedback, while the
solid curves incorporate geometrical regulation (a constant pathological
skeletal imbalance of -2 µm/yr is assumed). Typical bone microstructures
for cortical bone (bottom) and trabecular bone (top) in normal subjects
(left) and osteoporotic subjects (right) are also represented.
(ii) How do geometrical and mechanical feedbacks inter-
act?; (iii) What is the impact of geometrical feedback in
osteoporosis in terms of bone porosity and bone stiffness?
To address these questions we extend a previously de-
veloped mathematical model of bone remodelling [22–24].
This multiscale model takes into account both biochemical
and biomechanical regulations of bone remodelling. Bio-
chemical regulatory factors include the RANK–RANKL–OPG
pathways together with the action of TGFβ on bone cells.
Biomechanical regulation of bone formation and bone
resorption is mediated by the microscopic strain energy
density (SED) of the bone matrix. This strain energy den-
sity is calculated from a micromechanical homogenisation
scheme. The introduction of geometrical feedback due to
microscopic bone surface availability is elucidated through
a phenomenological relationship between the specific sur-
face and the vascular porosity obtained from various types
of bone [13].
2 Mathematical model of bone re-
modelling
Few mathematical models of bone remodelling include
explicitly biochemical interactions of bone cells that couple
bone resorption and bone formation. Lemaire et al. [25]
have proposed a bone cell population model that incorpo-
rates some of the most important known bone biology. This
cell population model was further developed by Pivonka
et al. to investigate the effect of RANKL expression on os-
teoblasts of varying maturity [23]. These models have
been shown to correctly capture important physiological
behaviours of bone remodelling both in bone homeostasis
and in bone pathologies [24, 26–28]. Recently, we have
proposed an extension of the model of Ref. [23] to include
a biomechanical regulatory mechanism to trigger bone cell
responses, leading to a fully coupled model of biochemical
and biomechanical regulations [22]. This model uses
a novel multiscale approach based on micromechanical
homogenisation of bone stiffness. It allows to consistently
calculate bone matrix strains at the osteocyte level. Osteo-
cytes convert this micromechanical signal into biochemical
signals to bone cells in the vascular space, effectively
providing a biomechanical feedback regulation of bone
remodelling.
In the following, we present an extension of the model
of Ref. [22] that incorporates the influence of microscopic
bone surface availability at various stages of the bone
remodelling sequence.
2.1 Fundamental biochemical and biome-
chanical regulation of bone remodelling
The biochemical regulatory mechanisms considered in the
model have been described in detail in Refs. [23, 24].
Three stages of osteoblast development are considered:
uncommitted osteoblast precursors (OBus), pre-osteoblasts
(OBps) and active osteoblasts (OBas). Similarly, three stages
of osteoclast development are considered: uncommitted
osteoclast precursors (OCus), pre-osteoclasts (OCps) and
active osteoclasts (OCas). Figure 2 schematically depicts
these bone cell types along with their biochemical, biome-
chanical and geometrical regulations. These regulations
are summarised sequentially in the following.
The generation of osteoblasts is assumed to be regulated
by transforming growth factor β (TGFβ) (a factor released
from the bone matrix during osteoclastic bone resorption)
while the generation of osteoclasts is assumed to be regu-
lated by RANKL and OPG (molecules in the receptor-activator
nuclear factor κB (RANK) system, that are expressed by
osteoblasts). TGFβ promotes the differentiation of uncom-
mitted osteoblast progenitors (OBu) into pre-osteoblasts
(OBp), but it inhibits the differentiation of pre-osteoblasts
into active osteoblasts (OBa). Furthermore, TGFβ promotes
osteoclast apoptosis (programmed cell death). RANKL is a
protein expressed on the surface of pre-osteoblasts. The
binding of RANKL to the receptor RANK found on pre-
osteoclasts promotes the differentiation of pre-osteoclasts
into active osteoclasts. However, this binding may be
prevented by the presence of OPG, a decoy receptor of
RANKL produced in soluble form by active osteoblasts. Fur-
thermore, the circulating parathyroid hormone PTH induces
RANKL expression and downregulates OPG expression by
osteoblasts to produce a systemic increase in available
RANKL, resulting in an increase in the formation and ac-
tivity of osteoclasts. The differentiation of uncommitted
osteoclast progenitors (OCus) into pre-osteoclasts (OCps)
requires signalling by both RANKL and macrophage colony-
stimulating factor (MCSF). All these signalling actions are
accounted for using mass action kinetics for the chemical
bindings between ligands and their receptors [29]. The
fraction of occupied receptors on a cell (i.e., bound to a
ligand) is assumed to determine the strength of the signal
received by the cell, and so is assumed to determine the
strength of the cell’s response.
The biomechanical regulatory mechanisms considered in
the model are described in detail in Ref. [22]. Mechanical
disuse is known to increase bone resorption by increasing
3
Figure 2 – Cell population model of bone remodelling, including several developmental stages of osteblasts (OBu, OBp, OBa) and osteoclasts (OCu, OCp,
OCa) and their biochemical regulation (PTH, RANK–RANKL–OPG, TGFβ, MCSF), biomechanical regulation (SED, "bm) and geometrical regulation (SV ) (see
text for further explanations).
the RANKL/OPG ratio, which increases the differentiation
of pre-osteoclasts into active osteoclasts. In the model,
this is implemented using a mechanically controlled RANKL-
production term, see Eq. (10). Mechanical overuse is
believed to increase bone formation by stimulating Wnt
signalling to pre-osteoblasts, which increases their prolif-
eration and ultimately leads to an increased population
of active osteoblasts [22, 30]. In the model, this is im-
plemented using a mechanically controlled proliferation of
pre-osteoblasts, see Eq. (11).
2.2 Geometrical and morphological charac-
teristics of bone: porosity and specific
surface
To represent the microstructure of bone at the tissue level,
the most important geometrical and morphological param-
eters are the vascular porosity ( fvas) and the specific surface
(SV ). In cortical bone, vascular porosity corresponds to
the so-called ‘Haversian canal’ system. In trabecular bone,
vascular porosity corresponds to the marrow space around
the trabecular struts [3]. The vascular compartment con-
tains all the bone cells considered in our model. Vascular
porosity is defined as the volume fraction of vascular pores,
i.e., the volume of vascular pores (Vvas) per tissue volume
(VT ):
2
fvas = Vvas/VT . (1)
The bone matrix volume fraction is defined in the same way
as the volume of bone matrix (Vbm) per tissue volume, i.e.:
fbm = Vbm/VT . (2)
We recall that all porosities at observation scales below
the vascular porosity, such as the lacunar porosity, and
the canaliculi connecting the lacunae, are not involved
in the remodelling process, i.e. the intricate biochemi-
cal processes take place within the vascular pore space
2The tissue volume VT is assumed to be of the order of 1–3 mm
3.
This volume corresponds to a representative volume element (RVE) large
enough to comprise several remodelling events (BMUs) [2], yet small
enough to represent spatial heterogeneity of bone tissue (in particular,
small enough to distinguish cortical bone and trabecular bone) [16].
(see also footnote 1). From Eqs (1)–(2), it follows that
fvas + fbm = 1. Typically, cortical bone exhibits a range of
porosities fvas ≈ 0.05–0.15 while trabecular bone exhibits
a range of porosities fvas ≈ 0.65–0.85.
The specific surface (or surface density) of a porous
material is defined as the interstitial surface area of the
pores (Sp) per tissue volume, i.e.:
SV = Sp/VT (3)
with dimensions [mm2/mm3]. Generally speaking, the
specific surface is an important quantity for a variety of
phenomena in porous media. For example, it determines
the adsorption capacity of industrial adsorbents and plays
an important role in determining the effectiveness of cat-
alysts and ion exchange columns and filters. It is also
related to the fluid conductivity or permeability of porous
media (see e.g. Ref. [31]). Experimentally, SV is commonly
estimated by adsorption methods, quantitative stereology,3
fluid flow and micro-computed tomography. As mentioned
above, in bone the specific surface is important as it
determines the available working area for osteoblasts and
osteoclats. The specific surface can also be expected to have
an influence on the transmission of specific signalling by
osteocytes in the bone matrix to osteoblasts and osteoclasts
developing in the vascular pores.
The microstructure of a material determines both the
porosity and the specific surface. Depending on the mi-
crostructure, different materials exhibit different values
for these quantities. Bone tissue spans a wide range of
porosities, each of which is characteristic of a particular
micro-architecture, and so of a particular value of the
specific surface. Based on a large number of experimental
data, Martin has provided a remarkable phenomenological
relationship between bone specific surface (SV ) and vascu-
lar porosity ( fvas) [13, Eq. (68)]:
SV ( fvas) = a fvas + b fvas
2 + c fvas
3 + d fvas
4 + e fvas
5, (4)
where the polynomial coefficients are estimated as a =
32.3, b = −93.9, c = 134, d = −101, and e = 28.8 (in
[mm−1]). In Figure 3, the relation (4) is plotted together
3Stereology is the study of three-dimensional properties of objects
observed in two-dimensional sections.
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Figure 3 – Relation between bone specific surface (SV ) and vascular
porosity ( fvas) (modified from Martin [13, Fig. 19]). Data points were
measured on histological sections and microradiographs of different types
of bone. Solid symbols: healthy bone; open symbols: diseased bone
(osteoporosis, osteogenesis imperfecta, and osteomalacia); circles: human
femoral bone; squares: human iliac crest; diamonds: human rib; trian-
gles: human vertebra. The maximum of the curve SV ( fvas) (thick solid
line, Eq. (4)) at fvas = f ∗vas ≈ 0.37 is indicated by dotted lines. The dashed
curves are obtained by varying the polynomial coefficients in Eq. (4) to
enclose most of the range of measurements.
with experimental data obtained from various types of
human bone (femur, iliac crest, vertebra, rib) both in health
and disease. The data and the curve SV ( fvas) show two
important characteristics: (i) all specimens approximately
follow the same SV ( fvas) curve independently of bone type
and with no significant difference between diseased and
healthy bone. This remarkable universality establishes the
curve SV ( fvas) as an intrinsic property of bone; (ii) the
specific surface exhibits a maximum at a porosity f ∗vas of
about 0.37, intermediate between cortical and trabecular
bone (bone at such porosity is denoted as ‘porous-compact’
bone).
In this work, we use Eq. (4) to include geometrical
regulation in the model as follows. The evolution of the
bone cell populations predicts the evolution of the vascular
porosity due to resorption by osteoclasts and formation by
osteoblasts. Eq. (4) then enables us to estimate changes in
the specific surface associated to the changes in porosity.
This change in microscopic bone surface availability is
in turn assumed to influence the evolution of the cell
populations.
2.3 Bone cell governing equations
In the model, osteoblasts and osteoclasts of different de-
velopmental stages are considered. The populations of os-
teoblasts and osteoclasts are therefore heterogeneous. The
composition of these populations is determined by follow-
ing individually the populations of each of the developmen-
tal stages of osteoblasts and osteoclasts mentioned above.
The evolution of these cell (sub)populations is transcribed
mathematically as so-called ‘rate equations’ [22, 23]. The
populations of uncommitted progenitor osteoblasts (OBus)
and uncommitted progenitor osteoclasts (OCus) are as-
sumed constant and so are not state variables. These
uncommitted cells represent a pool of progenitor (or stem)
cells that is assumed to be maintained by self-renewal
unlimitedly. The possibility for geometrical regulation is
included at each stage of osteoblast and osteoclast devel-
opment through functions of the specific surface, namely
gOBu(SV ), gOBp(SV ), gOCu(SV ) and gOCp(SV ) (see Figure 2). In
the following, we denote the bone cell densities within a
tissue sample (number of cells per unit volume) by their
symbol OBu, OBp, OBa, OCu, OCp, OCa. The concentrations of
the biochemical signalling molecules within a tissue sample
(number of molecules per unit volume) is also denoted
by their symbol TGFβ, RANKL, etc.4 Based on the above
descriptions of the biochemical, biomechanical, and geo-
metrical regulatory mechanisms, the governing equations
of the bone cell densities in the model are expressed as:
d
dt
OBp =
n
gOBu(SV )DOBu pi
TGFβ
act,OBu
o
OBu +
n
POBp Π
ψbm
act,OBp
o
OBp
−
n
gOBp(SV )DOBp pi
TGFβ
rep,OBp
o
OBp (5)
d
dt
OBa =
n
gOBp(SV )DOBp pi
TGFβ
rep,OBp
o
OBp − AOBa OBa (6)
d
dt
OCp =
n
gOCu(SV )DOCu pi
MCSF
act,OCu
piRANKLact,OCu
o
OCu
−
n
gOCp(SV )DOCp pi
RANKL
act,OCp
o
OCp (7)
d
dt
OCa =
n
gOCp(SV )DOCp pi
RANKL
act,OCp
o
OCp −
n
AOCa pi
TGFβ
act,OCa
o
OCa.
(8)
Below, we discuss the various quantities occurring in these
equations (see Refs [22, 23] for more details). The pa-
rameters DOBu , DOBp , DOCu , DOCp denote differentiation rate
parameters for uncommitted osteoblast progenitors, pre-
osteoblasts, uncommitted osteoclast progenitors and pre-
osteoclasts, respectively; POBp is a proliferation rate param-
eter for pre-osteoblasts; AOBa and AOCa are apoptosis rate
parameters for active osteoblasts and active osteoclasts.
Biochemical regulation of cell development is achieved
through so-called “activator” and “repressor” functions
of the biochemical signalling molecules TGFβ, MCSF and
RANKL as follows. The functions piTGFβact,OBa , pi
TGFβ
rep,OBp
, and
pi
TGFβ
act,OCa are activator and repressor functions regulating
osteoblast differentiation and osteoclast apoptosis based
on the concentration of TGFβ. The function piMCSFact,OCu is an
activator function regulating differentiation of OCus into
OCps based on the concentration of macrophage colony
stimulation factor (MCSF). The functions piRANKLact,OCu and pi
RANKL
act,OCp
are activator functions regulating osteoclast differentiation
based on the concentration of RANKL. For simplicity, we
assume that piRANKLact,OCu = pi
RANKL
act,OCp
. The equations governing
the evolution of the biochemical signalling molecules TGFβ,
MCSF, RANKL, RANK, OPG and PTH and the form of the activa-
tor and repressor functions are presented in Appendix A,
see Eqs (15)–(22). Tables 1–3 in Appendix A list the
dynamic quantities, the biochemical parameters and the
biomechanical quantities of the model.
4To align with common practice, we shall use the terminology ‘density’
for cells and ‘concentration’ for signalling molecules, even if the units are
chosen the same.
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Figure 4 – Microscopic strain energy density ψbm derived from the
micromechanical homogenisation procedure as a function of vascular
porosity fvas for the case of a uniaxial compressive loading Σ= Σunie3⊗e3
with Σuni =−30 MPa.
2.3.1 Mechanical feedback regulation
Biomechanical studies suggest that the strain energy den-
sity is an important quantity that determines bone adap-
tation to various mechanical loads. This quantity is com-
monly chosen in the literature due its scalar nature as a
measure of mechanical stimulus sensed by the bone cells to
drive bone adaptation [3,32].
The model of biomechanical regulation developed in
Ref. [22] similarly uses the strain energy density as the
signal conveying mechanical information to the bone cells.
However, as discussed in Ref. [22], it is paramount to
estimate consistently the bone matrix strain energy density
at the micro-scale where osteocytes sense this mechanical
signal and transduce it into a biochemical response. In
Ref. [22], we used a homogenisation procedure based
on Eshelby’s classical matrix inclusion problem and the
Mori-Tanaka scheme to estimate the microscopic strains
"bm generated at the level of the extravascular matrix
hosting the osteocytes, by the macroscopic loading of the
tissue. This homogenisation procedure leads to an intricate
dependence of the microscopic strain energy density of the
bone matrix, ψbm, upon the macroscopic stress tensor Σ
and the vascular porosity fvas:
ψbm =ψbm(Σ, fvas). (9)
In this paper, we will exemplify the effect of biomechanical
regulation for the situation of a constant uniaxial com-
pressive loading only (i.e., Σ = Σunie3 ⊗ e3 with Σuni =−30 MPa). For this situation, the dependence of ψbm upon
fvas is plotted in Figure 4. The reader is referred to Refs [14,
15, 22, 33] for the general mathematical specification of
ψbm and a detailed presentation of the homogenisation
procedure. As mentioned in Section 2.1, the biomechan-
ical regulation of bone remodelling is believed to operate
through different pathways for resorption and formation.
Following Ref. [22], the biomechanical regulation of bone
resorption is realised in the model via modulation of the
RANK–RANKL–OPG signalling pathway by the microscopic
strain energy densityψbm. The production rate of RANKL on
pre-osteoblasts, Pψbm
RANKL
, is assumed to be enhanced during
mechanical disuse:
Pψbm
RANKL
=
κ

1− ψbm
ψbm(t0)

, ψbm <ψbm(t0)
0, ψbm ≥ψbm(t0)
(10)
where κ is a parameter quantifying the strength of the
biomechanical transduction andψbm(t0) is the steady-state
value of the strain energy density. The steady state is
assumed to be an initial homeostatic state of bone remod-
elling, with no bone gain or loss. The increase in RANKL
production rate during mechanical disuse increases both
piRANKLact,OCu and pi
RANKL
act,OCp
in Eqs (7) and (8), and consequently
leads to increased osteoclast generation (see Appendix A,
Eqs. (18), (22)).
Following Ref. [22], the biomechanical regulation of
bone formation is realised in the model via modulation of
pre-osteoblast proliferation by the microscopic strain en-
ergy density ψbm. In Eq. (5), pre-osteoblasts are generated
both by differentiation from OBus and by self-expansion
through proliferation. The modulation of proliferation by
the strain energy density is expressed by an ‘activator’
function Πψbmact,OBp , defined as:
Πψbmact,OBp =

1
2
ψbm ≤ψbm(t0),
1
2
+
λ
2

ψbm
ψbm(t0)
− 1

, ψbm(t0)<ψbm <ψbm
∗,
1 ψbm
∗ ≤ψbm,
(11)
where λ is a constant parameter quantifying the strength
of the biomechanical transduction and, ψbm
∗ = (1 +
λ−1)ψbm(t0) is the minimum value of the strain energy
density for which Πψbmact,OBp = 1.
2.3.2 Geometrical feedback regulation
The four regulatory functions gOBu(SV ), gOBp(SV ), gOCu(SV )
and gOCp(SV ) in Eqs (5)–(8) include a geometrical feedback
at various stages of osteoblast and osteoclast development.
This enables us to distinguish two types of geometrical
action. Indeed, the modulation of the bone cell develop-
mental stages by the specific surface can be interpreted in
the model in terms of modulation of the initiation of new
remodelling events (BMU creation) and modulation of re-
sorption and formation within existing BMUs, as explained
in the following:
1. Initiation of new remodelling events. The initiation of
a new remodelling event is a localised process that
creates a new BMU. While the exact biochemical
mechanisms that lead to the creation of a new BMU
are poorly understood, it is believed that first steps in
this process are the recruitment of pre-osteoclasts and
pre-osteoblasts at the bone surface [3]. This recruit-
ment is thought to be controlled by osteocytes sensing
the local mechanical state of the bone matrix and
communicating with progenitor cells in the marrow
through the bone surface. The complex dependence
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of bone surface availability on the recruitment of pre-
osteoblasts and pre-osteoclasts is modelled by the
geometrical regulation of cell differentiation exerted
by the functions gOBu(SV ) and gOCu(SV ). Therefore,
the geometrical regulation by gOBu(SV ) and gOCu(SV )
models the influence of bone surface availability on
the initiation of new remodelling events, and so on
the number of BMUs in the representative volume
element, which in turn determines the bone turnover
rate [2]. This type of geometrical regulation of bone
remodelling is similar to the geometrical regulation
of the ‘activation frequency’ of BMUs used by Hazel-
wood et al. [21].
2. Modulation of resorption and formation within exist-
ing BMUs. Active osteoclasts can only resorb bone
from the bone surface. Similarly, active osteoblasts
are only observed to deposit new bone at the bone
surface. The maturation of pre-osteoblasts and pre-
osteoclasts into active cells thus depends on bone sur-
face availability. This dependence is modelled by the
geometrical regulation of cell differentiation exerted
by the functions gOBp(SV ) and gOCp(SV ). Therefore,
these functions dictate how many active osteoclasts
and active osteoblasts can form in BMUs that are
already remodelling bone (i.e., which contain already
pre-osteoblasts and pre-osteoclasts), and so how much
bone is resorbed and formed in existing BMUs, which in
turn determines bone balance. Note that while bone
surface availability is necessary for cell activation, it
is not sufficient. For instance, osteoclasts can only
become active if, in addition, their receptor RANK is
activated by the ligand RANKL.
Due to the different ways of action of bone surface on cell
differentiation explained above, the regulatory functions
gOBu(SV ), gOBp(SV ), gOCu(SV ) and gOCp(SV ) may take differ-
ent forms and can be complicated functions of the specific
surface SV . We take here a phenomenological approach and
assume that each of these functions can be represented by
a power law of SV :
gi(SV ) =
 SV
SV (t0)
ki
, with ki ≥ 0, i = OBu, OBp, OCu, OCp.
(12)
In Eq. (12), SV (t0) denotes the specific surface in the
bone remodelling steady state, which is assumed to be
homeostatic (no bone gain or loss, but a steady bone
turnover). The normalisation of SV by its steady-state value
SV (t0) ensures that in the steady state, gi = 1 ∀i, and
so that the steady state of the model is consistent with
previous models of bone remodelling without geometrical
regulation [22, 23]. The benefit of using a power-law
function of SV in Eq. (12) is that geometrical feedback
can be “switched off” by choosing ki = 0 ∀i in Eq. (12).
In this situation, not only the steady state, but also the
dynamical behaviour of the model of Ref. [22] (including
mechanical feedback) is retrieved. Mechanical feedback
is “switched off” by choosing κ = 0, λ = 0 in Eqs (10)
and (11). Note that when both geometrical and mechanical
feedbacks are “switched off”, the bone cell population
model of Refs [23, 24] is retrieved, except for a remaining
pre-osteoblast proliferation term in Eq. (5) that was not
accounted for previously.5
To reveal in which ways the morphology of the mi-
crostructure of bone may influence bone remodelling, we
will investigate the effects of several combinations of gOBu ,
gOBp , gOCu and gOCp in Section 3 and determine combinations
that lead to physiologically meaningful results.
2.4 Changes in porosity and bone matrix
fraction due to cell activity
The activity of osteoclasts and osteoblasts leads to the
removal and deposition of new bone. This activity modifies
the volume fraction of bone matrix in the tissue. Os-
teoblasts deposit osteoid, a collagen-rich substance which
later mineralises into new bone. Primary mineralisation
of osteoid is relatively fast: 70% of the maximum mineral
density is reached within a few days in humans [2]. Given
the much larger time spans involved in the remodelling
processes, it is fair to model the osteoblasts “instanta-
neously” depositing “fully” mineralised new bone matrix,
as was assumed in Refs [22–24]. We further assume that
the resorption rate of bone matrix kres by an individual
active osteoclast (in volume per unit time) is constant, and
that the rate of new bone matrix deposition kform by an
individual osteoblast (in volume per unit time) is constant.
The evolution of the vascular porosity and bone matrix
volume fraction are thus given by
d
dt
fvas =− ddt fbm =−kformOBa + kresOCa. (13)
2.5 Comparison with the model of geomet-
rical regulation of bone remodelling by
Martin
It is informative at this point to compare our formulation
of geometrical regulation of bone remodelling with that
proposed by Martin in Ref. [13]. The evolution of the
vascular porosity proposed by Martin is, in our notations
(see [13, Eq. (67)]):6
d
dt
fvas, Martin =−(kform δOBa λOBa − kres δOCa λOCa) SV (14)
where δOBa and δOCa are the active osteoblast and active os-
teoclast surface densities at an active bone site (number of
cells per unit surface), and λOBa and λOCa are the fractions of
the total available bone surface in which there is osteoblas-
tic and osteoclastic activity. The quantity kform δOBa λOBaSV
is the formation rate of bone matrix and corresponds to
kformOBa in our model. The quantity kres δOCa λOCaSV is the
resorption rate of bone matrix and corresponds to kresOCa
5Compared to Refs [23, 24], the differentiation rate of OBus to OBps
is reduced accordingly to ensure that the model converges to the same
steady state.
6In Ref. [13], Martin uses the symbol Sλ to denote only the fraction of
3D specific surface that is capable of remodelling. This excludes surfaces
of the lacunae-canaliculi system [17]. In this paper, we do not consider
surfaces of the lacunae-canaliculi system, and so Sλ in Ref. [13] is equal
to our definition of SV .
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in our model. To model an osteoporotic pathological con-
dition, Martin assumes a constant bone imbalance between
resorption and formation in remodelling BMUs. This imbal-
ance is modelled by setting (kform δOBa λOBa−kres δOCa λOCa) =−2 µm/year in Eq. (14), meaning that in average, a 2 µm-
thick layer of the bone surface is resorbed each year. The
results presented in Figure 1 were obtained by Martin in
Ref. [13] by integrating Eq. (14) with this constant imbal-
ance and with either SV ≡ 1 (no geometrical feedback) or
using the function SV ( fvas) presented in Eq. (4) to include
the effect of geometrical feedback.
A limitation of the formulation by Martin is that the de-
pendence of the rate of change of porosity upon SV does not
account for microscopic effects of bone surface availability
on the recruitment and development of bone cells. Indeed,
in Martin’s formulation, the complexity of osteoblast and
osteoclast recruitment and development at a remodelling
bone surface is embodied by the fractions λOBa and λOCa ,
but these fractions are assumed to be independent of SV .
Martin and others have interpreted Eq. (14) as the influ-
ence of geometrical regulation on the activation frequency
of BMUs [2, 13]. Indeed, the densities of active osteoblasts
and osteoclasts in Martin’s model are proportional to the
specific surface. Comparing Eqs (13) and (14), one sees
that OBa = λOBaSVδOBa and OCa = λOCaSVδOCa . Thus, an
increased specific surface represents increased numbers of
remodelling OBas and OCas, and so an increased number of
BMUs.
The strength of our model is to consider several stages in
the recruitment and development of osteoblasts and osteo-
clasts explicitly. This enables us to include a more detailed
geometrical feedback acting directly on these different
stages of the remodelling sequence. In our model, even
steady-state values of OBas and OCas are complex functions
of the specific surface. This complexity represent the im-
plicit dependence of λOBa and λOCa upon SV not accounted
for by Martin. Additionally, no mechanical feedback has
been considered by Martin. In Ref. [22], Scheiner et al.
have discussed the problem of neglecting mechanical feed-
back in models of bone remodelling applied to catabolic
bone diseases (such as osteoporosis), which leads to a
unlimited bone loss which is physiologically not observed.
This behaviour can be seen in Figure 1 for cortical bone
where the vascular porosity continues to increase (both
with and without geometrical regulation). It is known
from bone mineral density measurements in osteoporotic
patients that the increase in bone porosity in osteoporosis
slows down with time. The porosity eventually reaches an
upper bound whose value depends on the patient. We note
here that the long-term value of the vascular porosity fvas
reached with mechanical feedback in our model depends in
particular on the initial value of fvas (see Section 3).
3 Numerical Results and discussion
Having incorporated biochemical, biomechanical and ge-
ometrical regulation of bone remodelling we are now in
a position to investigate the effects of various regulatory
parameters on changes in bone cell numbers, vascular
porosity and bone stiffness. To compare our model with
the model suggested by Martin in Ref. [13], we simulate an
underlying osteoporotic condition as a perturbation from
the original (homeostatic) steady state situation.
Osteoporosis is a bone disease that leads to an increase
in porosity in both cortical and trabecular bone [18]. This
increase in porosity generates a progressive reduction in
bone stiffness and a higher fracture risk. To simulate an
osteoporotic condition in our model, we perturb the home-
ostatic steady state (a state with no bone loss or gain and a
constant bone turnover rate) by increasing the RANKL/OPG
ratio. This can be achieved in our model by prescribing
an excess of PTH concentration (see Refs. [23, 25]).7 The
osteoporotic condition is assumed to develop instantly from
an initial homeostatic state at time t0 (corresponding to
a middle biological age). To obtain a steady increase in
fvas of 0.01/year without geometrical regulation, as has
been assumed by Martin (see Figure 1), a continuous PTH
administration rate PPTH(t)≡ 500 pM/day has been applied
at all times t > t0. We denote by ∆tOP = t − t0 the time
elapsed since the onset of the osteoporotic condition. The
evolution of the system is followed for a period of time of
20 years from the onset of osteoporosis, i.e., 0 ≤ ∆tOP ≤
20 years. The initial values for vascular porosity of cortical
and trabecular bone have been chosen as f cort.vas = 0.05 and
f trab.vas = 0.75. For the simulations including biomechanical
regulation, a uniaxial compressive stress Σ = Σunie3 ⊗ e3
with Σuni = −30 MPa has been assumed to exert on the
representative volume element.
3.1 Simulation of osteoporosis: Evolution of
bone porosity and bone stiffness proper-
ties
Figure 5 shows the simulated evolution of bone cell den-
sities, vascular porosity ( fvas) and selected components of
the bone stiffness matrix (i.e., axial stiffness E3 and shear
modulus G12) in osteoporosis considering no geometrical
feedback and no mechanical feedback. The evolution of
bone cell densities exhibits a short transient for a period
of ≈ 30 days after the onset of osteoporosis (Figure 5a).
After this initial transient, OCas and OBas reach a new steady
state, in which resorption and formation are imbalanced
and lead to osteoporotic bone loss. Note that a short
time interval has been chosen in Figure 5a to demonstrate
the short transient cellular response, while a larger time
interval of 20 years is chosen to follow the evolution of
the vascular porosity, axial stiffness and shear modulus.
The progressive increase in vascular porosity is shown
7The physiological effect of PTH administration for bone remodelling
is complex and in particular, depends on the time course of the admin-
istration [34]. Continuous PTH administration (infusion) leads to bone
loss with increased turnover. However, intermittent PTH administration
(daily injections) leads to bone gain [34,35]. Only the ‘continuous’ action
of PTH is represented in our model [23, 25]. We have shown previously
that increasing PTH leads to an increase in the RANKL/OPG ratio, and so to
bone loss with higher turnover rate compared to the homeostatic bone
remodelling state [24, 28]. Increasing PTH concentration thus consists
in an adequate representation of osteoporosis in the present model. We
also note that the effect of PTH in bone remodelling is known to interact
synergistically with mechanical loading [36, 37]. Consistently with the
interpretation of increasing PTH as a representation of osteoporosis in our
model, we do not consider this synergistic interaction here.
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Figure 5 – Time evolutions for a simulated osteoporotic condition of (a)
bone cell densities (normalised to the initial homeostatic steady state) and
(b) the vascular porosities fvas, axial stiffnesses E3 and shear modulus G12
in both a cortical bone tissue sample and a trabecular bone tissue sample
under uniaxial compression. In this figure, no geometrical nor mechanical
feedback is considered.
in Figure 5b together with the associated reduction in
bone stiffness. After 20 years of osteoporosis, the normal
stiffness in the longitudinal direction of cortical bone, E3,
has dropped by about 20%, whereas the shear modulus of
cortical bone, G12, has dropped by about 40%. From these
results it is clear that the evolution of vascular porosity
drives the changes in bone stiffness differently for the
different components of the stiffness tensor [28]. Generally
speaking, an increase in fvas is always associated with a
reduction of bone stiffness properties. For conciseness, in
the following we will only present the effects of geometrical
and biomechanical regulation on the vascular porosity fvas
alone.
3.2 Geometrical regulation—effect on indi-
vidual stages of osteoblast and osteoclast
developments
We first present how geometrical regulation influences the
osteoporotic increase in bone porosity fvas without account-
ing for mechanical feedback, i.e., by setting κ = 0 pM/day
and λ = 0 in Eqs (10), (11). Based on the four regulatory
functions gOBu , gOBp , gOCu , and gOCp accounting for geomet-
rical regulation, we first performed 24 = 16 simulations
‘switching on’ or ‘off’ each of these regulatory functions to
investigate all different possible combinations. However, it
turns out that among all possible simulations there are only
three patterns which reflect the bone systems behaviour.
These patterns can best be studied by looking first at the
cases in which only a single regulatory function is ‘switched
on’ while all others are ‘switched off’ (i.e., identically
set to one) (Figure 6). We will present a selection of
combinations of geometrical regulation on several stages of
osteoblast and osteoclast development in Figures 7 and 8.
Figure 6a shows the influence of gOBu(SV ) on the increase
of vascular porosity in osteoporosis compared to the case
of no geometrical and no biomechanical regulations in
both cortical and trabecular bone. The time evolution of
the porosity fvas(t) in Figure 6a clearly shows that while
gOBu(SV ) reduces bone loss in cortical bone it accelerates
bone loss in trabecular bone. The strength of this reg-
ulation depends on the exponent kOBu of the normalised
geometrical regulatory function in Eq. (12). Exponents
in the range 0.3 ® kOBu ® 1 exhibit a relatively strong
regulatory effect on the evolution of the disease, while
exponents in the range 0 < kOBu ® 0.2 only exhibit a
moderate effect. Interestingly, the mechanism of action
of gOBu is opposite to the geometrical regulation obtained
by Martin [13] (see Figure 1). In cortical bone, the
osteoporotic increase in fvas induces an increase in SV (see
Figure 4), and so an increase of gOBu(SV ). This increases in
turn the generation of osteoblasts, which has an anabolic
(i.e., bone forming) effect and stabilises the osteoporotic
loss of bone [23, 25]. By contrast, in trabecular bone the
osteoporotic increase in fvas induces a decrease in SV (see
Figure 4), and so a decrease of gOBu(SV ). This decreases
in turn the generation of osteoblasts, which accelerates the
osteoporotic loss of bone.
While this scenario can be understood from a theoretical
point of view, it has to be emphasised that it is probably
physiologically unrealistic. As argued in Section 2.3.2, the
geometrical regulation of OBu differentiation is associated
with the creation of a new remodelling event, i.e., of
a new BMU. However, both OBu differentiation and OCu
differentiation are activated in such an event. Here, the
consideration of a geometric regulation on OBu differenti-
ation alone represents the initiation of a formation event
and is not associated with a joint initiation of a resorption
event. To represent the geometrical regulation of BMU
creation, both gOBu(SV ) and gOCu(SV ) should act together
(see Figures 7 and 8).
Figure 6b shows the influence of gOBp(SV ) on the increase
of fvas in osteoporosis. In this figure, fvas is only weakly
affected by the geometrical feedback in both cortical and
trabecular bone. The effect of bone surface availability on
the differentiation of pre-osteoblasts into active osteoblasts
modelled by gOBp(SV ) does not seem to affect the bone
remodelling balance significantly in the first 10 years. In
fact, neither the population of active osteoblasts nor the
population of active osteoclasts is affected significantly,
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Figure 6 – Influence of geometrical regulation on the increase of vascular porosity in osteoporosis. In this figure, geometrical regulation is included at a
single stage of osteoblast or osteoclast development only. The numerical simulations are initiated from either cortical bone (lower curves) or trabecular
bone (upper curves). The effect of several strengths k of the geometrical regulations are shown (corresponding to the exponent of the power law in
Eq. (12)). The case k = 0 corresponds to no geometrical feedback. (a) Geometrical regulation of OBu differentiation only; (b) geometrical regulation of
OBp differentiation only; (c) geometrical regulation of OCu differentiation only; (d) geometrical regulation of OCp differentiation only.
while the population of pre-osteoblasts is decreased in cor-
tical bone and increased in trabecular bone (not shown).
The increased differentiation rate of pre-osteoblasts into
active osteoblasts in cortical bone (due to the increase
in the available bone surface) depletes the population of
pre-osteoblasts. The population of active osteoblasts is
thus derived from a smaller pool of pre-osteoblasts that
are differentiating faster, and therefore stays relatively
constant. The opposite effect occurs in trabecular bone,
i.e., a larger pool of pre-osteoblasts is created but they are
differentiating into active osteoblasts more slowly.
Figure 6c shows the influence of gOCu(SV ) on the increase
of fvas in osteoporosis. The behaviour of fvas obtained for
this type of geometrical regulation is in general agreement
with the geometrical regulation obtained by Martin [13]
(see Figure 1), i.e., geometrical regulation leads to in-
creased bone loss in cortical bone and decreased bone
loss in trabecular bone. In cortical bone, the increase
in gOCu(SV ) due to the osteoporotic condition leads to
an increase in osteoclastogenesis, which by biochemical
coupling also increases (although to a lesser extent) the
population of osteoblasts. This results in a high turnover
rate with a catabolic bias, i.e., a high rate of bone loss.
In trabecular bone, the situation is reversed since gOCu(SV )
decreases with the evolution of the osteoporotic condition.
A state with lower turnover rate and a reduction in resorp-
tion is reached. The low turnover rate explains the reduced
amplitude of the response in trabecular bone compared to
that seen in cortical bone.
The strength of the geometrical regulation is determined
by the value of kOCu and is seen to strongly affect bone
balance. In particular for the case of strong modulation,
i.e., kOCu = 1, a rapid acceleration of cortical bone loss
occurs over the first 10 years of osteoporosis. At nearly
10 years, a transition is taking place leading to a reduction
in the rate of bone loss. This behaviour is due to the
fact that at this time, the bone porosity reaches the critical
value fvas
∗ ≈ 0.37 at which the specific surface is maximum
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(see Figure 3). In the first 10 years of osteoporosis, fvas
is in the ascending branch of SV ( fvas) and so gOCu(SV ) in-
creases, while after reaching the maximum specific surface,
gOCu(SV ) decreases, which leads to a reduction in the rate
of bone loss. Over 20 years, the original cortical bone
has been resorbed enough to reach trabecular porosities.
Such a strong effect of bone remodelling on bone porosity
is normally not physiologically seen. However, it is possible
that in osteoporosis, a locally strong geometrical feedback
may help initiate or accentuate the observed ‘trabeculari-
sation’ of bone, by which cortical bone is progressively lost
and transformed into trabecular bone at the endocortical
wall, leading to cortical wall thinning and expansion of
the medullary cavity [19, 38–40]. Indeed, in bone, the
endocortical wall exhibits the highest specific surface and
is known to be highly remodelling. It can be expected that
geometrical regulation plays a particularly significant role
in this region of bone.
Figure 6d shows the influence of gOCp(SV ) on the increase
of fvas in osteoporosis. This influence is qualitatively similar
to that of gOCp shown in Figure 6a, i.e., a reduction in
bone loss in cortical bone and an increase in bone loss
in trabecular bone. However, the geometrical regulation
modelled by gOCp is less pronounced than the geometrical
regulation modelled by gOBu .
3.3 Geometrical regulation—combined ef-
fect on several stages of osteoblast and
osteoclast developments
As mentioned previously, a geometrical regulation of the
creation of new remodelling events (i.e. new BMUs) should
involve a regulation of both the recruitment of osteoclasts
and the recruitment of osteoblasts (see Section 2.3.2).
In Figure 7a, we show the combined influence of both
gOCu(SV ) and gOBu(SV ) on the increase of fvas in osteoporo-
sis. The exponents kOCu and kOBu measuring the strength
of the geometrical regulation are assumed identical. By
comparing with the individual influences of gOBu(SV ) and
gOCu(SV ) in Figure 7a and 7c, one sees that the geomet-
rical regulation of osteoblast recruitment overrides that
of osteoclast recruitment. As a consequence, the overall
behaviour is opposite to that obtained by Martin [13] for
the geometrical regulation of the creation of new BMUs (see
Figure 1).
By contrast, in Figure 7b, the geometrical regulation
of the last stage of osteoclast differentiation by gOCp(SV )
and the geometrical regulation by gOBp(SV ) of the last
stage of osteoblast differentiation (modelling a regulation
of the activation of cells within existing BMUs) seem to
compensate each other and to result in an evolution of
the porosity that is almost unaffected by geometrical feed-
back. The geometrical regulations assumed in Figures 7a
and 7b represent different natures of the influence of bone
surface availability on bone remodelling (see Section 2).
Therefore, our simulations suggest that for the simulated
evolution of bone porosity in osteoporosis, the influence of
surface availability is significantly stronger on the creation
of new remodelling events (new BMUs) (Figure 7a) than on
the activation of bone cells within already active remod-
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Figure 7 – Combined influence of several geometrical regulations on the
increase of vascular porosity in osteoporosis. The numerical simulations
are initiated from either cortical bone (lower curves) or trabecular bone
(upper curves). The effect of several strengths k of the geometrical
regulations are shown (corresponding to the exponent of the power law
in Eq. (12)). The case k = 0 corresponds to no geometrical feedback.
(a) Joint geometrical regulation of both OBu differentiation and OCu
differentiation; (b) joint geometrical regulation of both OBp differentiation
and OCp differentiation.
elling sites (within existing BMUs).
In Figure 8, we show that a similar influence of geo-
metrical regulation of BMU creation as that obtained by
Martin [13] can be retrieved in our model by modifying
the relative strengths of the regulatory functions gOBu(SV )
and gOCu(SV ) via the exponents kOBu and kOCu . The vas-
cular porosity can exhibit a wide range of behaviours,
interpolating between the situation of Figure 6a (kOBu =
1, kOCu = 0) and the situation of Figure 6c (kOBu = 0,
kOCu = 1). We conclude that geometrical feedback has the
potential to significantly influence the evolution of bone
diseases. However, complex biochemical coupling between
osteoblasts and osteoclasts makes it difficult to predict the
relative strength of the influence of geometrical regulation
on osteoblast and osteoclast developments.
Finally, we note that because the curve SV ( fvas) exhibits a
maximum at fvas
∗ ≈ 0.37 (see Figure 3), geometrical feed-
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Figure 8 – Influence of the geometrical regulation of BMU creation on the
increase of vascular porosity in osteoporosis. Different strengths for the
geometrical regulation of OBu differentiation and OCu differentiation are
investigated via the exponents kOBu and kOCu of the regulatory functions
gOBu (SV ) and gOCu (SV ): kOBu = 0, kOCu = 0 (no geometrical regulation,
thin dashed lines); kOBu = 1, kOCu = 0.1 (thick dashed lines) and kOBu =
0.1, kOCu = 1 (thick solid line).
back always induces opposite behaviours for the evolution
of vascular porosity in cortical bone (for which fvas < fvas
∗)
and in trabecular bone (for which fvas > fvas
∗).
3.4 Coupled geometrical and mechanical
regulations
Figure 9 shows the effect of adding a mechanical regulation
of bone remodelling for the evolution of the vascular poros-
ity. The geometrical regulation considered in Figure 9 (see
dotted line) is assumed to represent the influence of bone
surface availability for BMU creation as in Figure 8, solid
line. Two strenghts of the biomechanical transduction are
illustrated (i.e., λ = 0.1 and λ = 0.5 in Eq. (11)). Figure 9
suggests that mechanical feedback has the potential to pro-
gressively override both the evolution of osteoporosis and
the influence of geometrical regulation. Indeed, mechani-
cal feedback is seen to stabilise bone balance, irrespective
of whether geometrical feedback stabilises or destabilises
bone balance in osteoporosis. Such a stabilisation of bone
loss is clinically observed in osteoporotic patients.
Similarly to the simulations by Scheiner et al. [22],
mechanical feedback counteracts bone loss in osteoporosis
both in cortical and trabecular bone, on a time scale that
depends on the strength of mechanical regulation (i.e., on
the parameter λ). Interestingly, in our simulations with
geometrical feedback, the strength λ of the mechanical
regulation also has an influence on the steady-state value
of the porosity attained. This is to be contrasted to the
situation without geometrical feedback in which no such
influence was observed [22]. In fact, without geomet-
rical feedback, the vascular porosity fvas enters the right
hand side of the governing equations (5)–(8), (13) only
implicitly via the strain energy density ψbm, see Eq. (9).
Consequently, the steady-state value of fvas is uniquely
determined by the steady-state value of the strain energy
density,ψbm(t0), and the macroscopic loading Σ, which are
themselves independent of the strength λ of biomechanical
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Figure 9 – Influence of coupled geometrical and mechanical regulation of
bone remodelling on the increase of vascular porosity in osteoporosis. The
evolution of fvas without geometrical regulation and without mechanical
regulation is shown as dashed lines. The inclusion of geometrical
regulation without mechanical regulation is shown as dotted lines. This
geometrical regulation is assumed identical to the solid line in Figure 8,
i.e., kOBu = 0.1, kOCu = 1, kOBp = kOCp = 0. Two cases of coupled
geometrical and mechanical regulations are shown as solid lines for two
strengths λ of the biomechanical regulation: λ= 0.1 (thin solid lines) and
λ= 0.5 (thick solid lines).
regulation [22]. With geometrical feedback, additional
dependences upon the vascular porosity fvas are added in
the governing equations for the bone cells, Eqs (5)–(8).
Consequently, the steady-state value of fvas now depends
in addition on the biochemical and cellular state of the
system, which depends in turn on the strength λ of the
biomechanical regulation of the bone cells.
From the above discussion, it is clear that the coupling
between the geometrical and mechanical feedbacks is effec-
tively mediated by the biochemical and cellular state of the
system. In osteoporotic patients, both a geometrical and a
mechanical feedback are present at the same time, as well
as biochemical and hormonal dysregulations underlying
the establishment of osteoporosis. The interdependence
between the biochemical and hormonal dysregulations in
osteoporosis, geometrical feedback and mechanical feed-
back, is not trivial to elucidate. Physiologically, it is ex-
pected that all these influences play a role for the evolution
of bone vascular porosity. Our mathematical model is a first
attempt to integrate these influences and help understand
their contribution for clinically observed changes of bone
porosities in osteoporotic patients.
4 Conclusions
In this paper we developed a computational model of bone
remodelling that takes into account biochemical, biome-
chanical and geometrical regulations of bone cells. The
biochemical regulation of the bone cells is based on the
model developed in Refs [23, 24]. The biomechanical
regulation of the bone cells is based on the model devel-
oped in Ref. [22], in which a continuum micromechanical
approach is used to consistently link bone cell responses
with mechanical properties of bone. The new contribution
of this paper is the inclusion of a geometrical regulation
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of bone cells in the model. Geometrical feedbacks were
included at several developmental stages of osteoblasts
and osteoclasts to represent the influence of microscopic
bone surface availability for various bone microstructures.
We investigated the influence of a geometrical regulation
of bone cells in bone remodelling both without and with
consideration of biomechanical regulation for a simulated
osteoporotic condition. From the numerical simulations,
we identified the following actions of geometrical and
mechanical regulation on bone remodelling:
• Geometrical regulation of bone remodelling may play
an important role for the initiation of new BMUs as
described by the combined effect of the geometri-
cal regulatory functions gOBu and gOCu acting on OBu
differentiation and OCu differentiation; in particular
geometrical regulation of OCus via gOCu seems to be
most important to retrieve similar evolutions of bone
porosities in osteoporosis as obtained by Martin [13];
• Geometrical regulation of BMU creation affects cortical
and trabecular bone in opposite ways in osteoporosis:
while bone resorption is enhanced in cortical bone
due to the increase in specific surface with increasing
porosity, bone resorption is slowed down in trabecular
bone due to the decrease in specific surface with
increasing porosity;
• Geometrical regulation of the activation of osteoblasts
and osteoclasts in existing BMUs seems to play a sec-
ondary role for the evolution of osteoporosis. While
the specific surface can influence the differentiation
of bone precursor cells into active resorbing/forming
cells, no significant influence on bone porosity was
observed in our simulations.
• Our simulations suggest that geometrical regulation
may play a role in osteoporosis for the initiation and/
or accentuation of the observed ‘trabecularisation’ of
bone at the endocortical wall. At the endocortical wall,
the specific surface and bone turnover are high and so
the effects of a geometrical feedback can be expected
to be significant;
• Our simulations of coupled geometrical and mechan-
ical regulations suggest that the stabilisation of bone
loss observed clinically in osteoporotic patients is
probably accelerated by geometrical feedback in tra-
becular bone, but is probably slowed down by geo-
metrical feedback in cortical bone.
• Both mechanical and geometrical feedbacks are im-
portant to account for in our model of bone remod-
elling. Mechanical feedback enables the local porosity
of bone tissue fvas to stabilise to a well-defined value
within [0, 1]. Geometrical feedback enables this value
to be not only determined by the external loading of
the tissue, but also by the biochemical and cellular
state of the system, as would be expected physiolog-
ically.
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Appendix A Model description
In this appendix, we complete the mathematical descrip-
tion of the model and give the values of the parameters.
The nomenclature used in the paper is split into three
tables. Table 1 lists dynamics quantities involved in the
governing equations of the bone cells and bone porosity,
Eqs (5)–(8), (13). Table 2 lists all the parameters relevant
to the biochemical regulation of the model. Table 3 lists
quantities involved in the biomechanical regulation of the
model.
Concentrations of the biochemical signalling molecules
As in Ref. [22–24,26], the concentration of the biochemical
signalling molecules are governed by rate equations based
on mass action kinetics. Ligand–receptor binding reactions
occur on a time scale much faster than the characteristic
times of cellular response (such as differentiation, apop-
tosis). The rate equations for the biochemical signalling
molecules can therefore be taken in their steady state (see
Refs. [23,26] for details). This gives:
TGFβ(t) = nbone
TGFβ
kresOCa(t)/D˜TGFβ (15)
RANK(t) = N RANK
OCp
OCp(t), (16)
OPG(t) =
βOPG
OBa
OBa(t)piPTHrep,OB
βOPG
OBa
OBa(t)piPTHrep,OB/OPGmax + D˜OPG
, (17)
RANKL(t) =
RANKLeff

βRANKL + PψbmRANKL
βRANKL + D˜RANKL RANKLeff

1+ K[RANKL–OPG]OPG+ K[RANKL–RANK]RANK
. (18)
PTH(t) =

PPTH(t) + βPTH

/D˜PTH. (19)
In Eq. (18), RANKLeff is the maximum concentration of
RANKL (also referred to as effective carrying capacity),
which is regulated by the parathyroid hormone PTH:
RANKLeff = N
RANKL
OBp
OBp pi
PTH
act,OB, (20)
where N RANKL
OBp
is the maximum number of membrane-bound
RANKL molecules that can be expressed on a single pre-
osteoblast (see Refs. [23, 24] for more details). In this
work, the concentration of MCSF, and so the quantity
piMCSFact,OCu , are assumed constant (see below and Table 2).
The additional production rate of PTH in Eq. (19), PPTH(t),
is used to increase the normal systemic levels of PTH
to simulate an osteoporotic condition (see comments in
Section 3).
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Activator and repressor functions The regulation of the
bone cell behaviours (such as differentiation, apoptosis,
expression rate of a ligand) by the biochemical signalling
molecules is modelled in Eqs (5)–(8) by so-called “ac-
tivator” functions piLact,A and “repressor” functions pi
L
rep,A,
where L denotes the signalling molecule (ligand) and A
the signalled cell. These activator and repressor functions
represent the strength of the response of the cell to the
signal mediated by the ligand and are assumed to be given
by:
piLact,A =
L
L+ kLA
, piLrep,A = 1−piLact,A =
1
L+ kLA
, (21)
where kLA is the dissociation binding constant between the
ligand and its receptor on the cell. The quantity piLact,A
represents the fraction of the receptors on the cell A that are
bound to a ligand L (see Refs. [23, 25] for more details).
For example, the activator functions piRANKLact,OCu and pi
RANKL
act,OCp
are
defined as:
piRANKLact,OCu = pi
RANKL
act,OCp
=
RANKL
RANKL+ kRANKL
OC
. (22)
where kRANKL
OC
is the dissociation binding constant between
RANKL and the RANK receptor on OCus and OCps, and RANKL is
the free (unbound) RANKL concentration given by Eq. (18).
Steady-state values The geometrical and biomechanical
regulations of the bone cells is normalised by the steady-
state values. These values depend in particular on the
initial bone porosity, and so are calculated prior to evolving
the system.
Table 1 – Dynamic quantities in the governing equations, Eqs (5)–(8),
(13)
SymbolUnit Description
OCp pM density of pre-osteoclasts
OCa pM density of active osteoclats
OBp pM density of pre-osteoblasts
OBa pM density of active osteoblasts
TGFβ pM concentration of transforming growth factor β
RANK pM concentration of receptor-activator nuclear factor κB
RANKL pM concentration of receptor-activator nuclear factor κB
ligand
OPG pM concentration of osteoprotegerin
PTH pM concentration of parathyroid hormone
fvas – volume fraction of vascular pores
SV – specific surface
ψbm MPa microscopic strain energy density of the bone matrix
Table 2 – Biochemical parameters
Symbol Value Description
OCu 1 · 10−3 pM density of uncommitted osteoclast
progenitors
OBu 1 · 10−3 pM density of uncommitted osteoblast
progenitors
kres 200 pM
−1day−1 daily volume of bone matrix re-
sorbed per osteoclast
kform 40 pM
−1day−1 daily volume of bone matrix formed
per osteoblast
DOCu 4.2/day OCu → OCp differentiation rate pa-
rameter
DOCp 2.1/day OCp → OCa differentiation rate pa-
rameter
AOCa 5.65/day OCa apoptosis rate parameter
DOBu 0.7/day OBu → OBp differentiation rate pa-
rameter
DOBp 0.166/day OBp → OBa differentiation rate pa-
rameter
POBp 0.021/day OBp proliferation rate parameter
AOBa 0.111/day OBa apoptosis rate
piMCSFact,OCu 0.5 value of the activator function of
MCSF for OCu→ OCp differentiation
kRANKL
OC
5.68 pM dissociation binding constant for
RANKL binding on OCu and OCp
kTGFβ
OCa
5.63 · 10−4 pM dissociation binding constant for
TGFβ binding on OCa
kTGFβ
OBu
5.63 · 10−4 pM dissociation binding constant for
TGFβ binding on OBu
kTGFβ
OBp
1.75 · 10−4 pM dissociation binding constant for
TGFβ binding on OBp
kPTH
OB,act 150 pM dissociation binding constant for PTH
binding on OB (in piPTHact,OB)
kPTH
OB,rep 0.222 pM dissociation binding constant for PTH
binding on OB (in piPTHrep,OB)
k[RANKL–RANK] 0.034/pM association binding constant for
RANKL and RANK
k[RANKL–OPG] 0.001/pM association binding constant for
RANKL and OPG
β RANKL 1.68 · 102 pM/day production rate of RANKL
βPTH 250pM/day production rate of systemic PTH
PPTH 500pM/day continous administration rate of PTH
to model osteoporosis
β OPG
OBa
1.62 · 108/day production rate of OPG per OBa
N RANKL
OBp
2.7 · 106 maximum number of RANKL per OBp
N RANK
OCp
1 · 104 number of RANK receptors per OCp
OPGmax 2 · 108 pM OPG density at which endogeneous
production stops
nbone
TGFβ
0.01pM density of TGFβ stored in the bone
matrix
D˜TGFβ 2/day degradation rate of TGFβ
D˜RANKL 10/day degradation rate of RANKL
D˜OPG 0.35/day degradation rate of OPG
D˜PTH 86/day degradation rate of PTH
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Table 3 – Biomechanical quantities
Symbol Value Description
Σ Σunie3 ⊗ e3, macroscopic stress tensor
Σuni =−30 MPa
"bm microscopic strain tensor of the bone
matrix
ψbm microscopic strain energy density of the
bone matrix
κ 1 · 105 pM/day strength of biomechanical transduction
of bone resorption
λ 0.1 or 0.5 strength of biomechnical transduction of
bone formation
15
References
[1] Taylor D, Hazenberg JG, Lee TC (2007). Living with cracks:
Damage and repair in human bone. Nat. Mat. 6:263–268
[2] Parfitt AM (1983). The physiological and clinical signifi-
cance of bone histomorphometric data. In Recker RR (Ed.),
Bone histomorphometry: Techniques and interpretation. CRC
Press, Boca Raton, pp. 143–223.
[3] Martin RB, Burr DB and Sharkey NA (1998). Skeletal Tissue
Mechanics (New York: Springer)
[4] Parfitt A M (1994) Osteonal and hemi-osteonal remodeling:
the spatial and temporal framework for signal traffic in
adult human bone. J. Cell. Biochem. 55:273–286
[5] Martin TJ (2004) Paracrine regulation of osteoclast forma-
tion and activity: Milestones in discovery. J. Musculoskel.
Neuron. Interact. 4:243–253
[6] Roodman GD (1999) Cell biology of the osteoclast. Exp.
Hematology 27:1229–1241
[7] Frost HM (1987). Bone “mass” and the “mechanostat”: A
proposal. Anat. Rec. 219:1–9
[8] Frost HM (1990). Skeletal structural adaptations to me-
chanical usage (SATMU): 2. Redefining Wolff’s law: The
remodelling problem. Anat. Rec. 226:414–422
[9] Frost HM (2003). Bone’s mechanostat: A 2003 Update.
Anat. Rec. 275A:1081–1101
[10] Smit TH and Burger EH (2000). Is BMU-coupling a strain-
regulated phenomenon? A finite element analysis. J. Bone
Miner. Res. 15:301–307
[11] Burger EH, Klein-Nulend J and Smit TH (2003) Strain-
derived canalicular fluid flow regulates osteoclast activity
in a remodelling osteon—a proposal. J. Biomech. 36:1453–
1459
[12] Lee TC, Staines A and Taylor D (2002) Bone adaptation to
load: microdamage as a stimulus for bone remodelling. J.
Anat. 201:437–446
[13] Martin RB (1984). Porosity and specific surface of bone.
Crit. Rev. Biomed. Eng. 10:179–222
[14] Hellmich C, Ulm F-J and Dormieux L (2004). Can the
diverse elastic properties of trabecular and cortical bone be
attributed to only a few tissue-independent phase proper-
ties and their interactions? Biomechan. Model. Mechanobiol.
2:219–238
[15] Fritsch A and Hellmich C (2007). “Universal” microstruc-
tural patterns in cortical and trabecular, extracellular and
extravascular bone materials: Micromechanics-based pre-
diction of anisotropic elasticity. J. Theor. Biol. 244:597–620
[16] Grimal Q, Raum K, Gerisch A and Laugier P (2011).
A determination of the minimum sizes of representative
volume elements for the prediction of cortical bone elastic
properties. Biomech. Model. Mechanobiol. 10:925–937
[17] Martin RB (1972). The effects of geometrical feedback in
the development of osteoporosis. J. Biomech. 5:447–455
[18] Nishiyama KK, Macdonald HM, Buie HR, Hanley DA and
Boyd SK (2010). Postmenopausal women with osteopenia
have higher cortical porosity and thinner cortices at the
distal radius and tibia than women with normal aBMD: an
in vivo HR-pQCT study. J. Bone Miner. Res. 25:882–890
[19] Cooper DML, Thomas CDL, Clement JG, Turinsky AL,
Sensen CW and Hallgrímsson B (2007). Age-dependent
change in the 3D structure of cortical porosity at the human
femoral midshaft. Bone 40:957–965
[20] Stevenson JC and Marsh M (2007). An atlas of osteoporosis,
3rd Ed. (London, Informa Healthcare)
[21] Hazelwood SJ, Martin RB, Rashid MM and Rodrigo JJ
(2001). A mechanistic model for internal bone remodeling
exhibits different dynamic responses in disuse and over-
load. J. Biomech. 34:299–308
[22] Scheiner S, Pivonka P, et al.(2012). Mechanobiological
regulation of bone remodeling—Theoretical development
of a coupled systems biology–micromechanical approach.
Preprint: arXiv:1201.2488
[23] Pivonka P, Zimak J, Smith DW, Gardiner BS, Dunstan CR,
Sims NA, Martin TJ and Mundy GR (2008). Model structure
and the control of bone remodeling: A theoretical study.
Bone 43:249
[24] Pivonka P, Zimak J, Smith DW, Gardiner BS, Dunstan CR,
Sims NA, Martin TJ and Mundy GR (2010). Theoretical
investigation of the role of the RANK–RANKL–OPG system in
bone remodeling. J. Theor. Biol. 262:306–316
[25] Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LJ (2004).
Modeling the interactions between osteoblast and osteo-
clast activities in bone remodeling. J. Theor. Biol. 229:293–
309
[26] Buenzli PR, Pivonka P, Smith DW (2011). Spatio-temporal
structure of cell distribution in Bone Multicellular Units: A
mathematical model. Bone 48:918–926
[27] Wang Y, Pivonka P, Buenzli PR, Smith DW and Dunstan CR
(2011). Computational Modeling of Interactions between
Multiple Myeloma and the Bone Microenvironment. PLoS
ONE 6(11): e27494
[28] Scheiner S, Pivonka P, and Dunstan CR (2012) Computer
simulation-based modeling of the pharmaceutical interven-
tion of postmenopausal osteoporosis by denosumab. To
appear in the Proceedings of the 11th Biennal Conference
on Engineering Systems Design and Analysis ASME 2012,
July 2012, Nantes, France
[29] Lauffenburger DA and Linderman JJ (1993). Receptors:
models for binding, trafficking, and signaling. (New York:
Oxford Univ. Press)
[30] Bonewald LF and Jonhson ML (2008). Osteocytes,
mechanosensing and Wnt signaling. Bone 42:606–615
[31] Dullien FAL (1992). Porous media. Fluid transport and pore
structure, 2nd Ed. (San Diego: Academic Press)
[32] van Oers, RFM, Ruimerman R, Tanck E, Hilbers PAJ, and
Huiskes R (2008). A unified theory for osteonal and hemi-
osteonal remodeling. Bone 42:250–259
[33] Hellmich C, Kober C and Erdmann B (2008).
Micromechanics-based conversion of CT data into
anisotropic elasticity tensors, applied to FE simulations of
a mandible. Ann. Biomed. Eng. 36:108–122
[34] Frolik CA, Black EC, Cain RL, Satterwhite JH, Brown-
Augsburger PL, Sato M and Hock JM (2003). Anabolic and
catabolic bone effects of human parathyroid hormone (1-
34) are predicted by duration of hormone exposure. Bone
33:372–379
[35] Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R,
and Hock JM (2001). Intermittently administered human
parathyroid hormone(1-34) treatment increases intracor-
tical bone turnover and porosity without reducing bone
strength in the humerus of ovariectomized cynomolgus
monkeys. J. Bone Miner. Res. 16:157-165
[36] Ma Y, Jee WS, Yuan Z, Wei W, Chen H, Pun S, Liang H and
Lin C (1999). Parathyroid hormone and mechanical usage
have a synergistic effect in rat tibial diaphyseal cortical
bone. J. Bone Miner. Res. 14:439-448
16
[37] Turner RT, Lotinun S, Hefferan TE, and Morey-Holton E
(2006). Disuse in adult male rats attenuates the bone
anabolic response to a therapeutic dose of parathyroid
hormone. J. Appl. Physiol. 101:881-886
[38] Mayhew PM, Thomas CDL, Clement JG, Loveridge N, Beck
TH, Bonfield W, Burgoyne CJ and Reeve J (2005). Relation
between age, femoral neck cortical stability, and hip frac-
ture risk. Lancet 366:129–135
[39] Thomas CDL, Feik SA and Clement JG (2005). Regional
variation of intracortical porosity in the midshaft of the
human femur: age and sex differences. J. Anat. 206:115–
125
[40] Seeman E (2002). Osteoporosis II. Pathogenesis of bone
fragility in women and men. Lancet 359:1841–1850
[41] Parfitt AM (1983). Stereological basis of bone histomor-
phometry: Theory of quantitative microscopy and recon-
struction of the third dimension. In Recker RR (Ed.),
Bone histomorphometry: Techniques and interpretation. CRC
Press, Boca Raton, pp. 53–87.
17
